an antibody-dependent cellular cytotoxicity assay revealed cytotoxicity of about 37 % of sera from patients with diffuse scleroderma and the transitional form but also of a proportion of sera from patients with crest syndrome with pronounced vascular changes .
C0036421
diffuse scleroderma
C0206138
crest syndrome